News Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company Jun 17, 2019
News Cyclerion Announces the Appointment of Andreas Busch, Ph.D., as Chief Innovation Officer Jun 17, 2019
News Cyclerion Launches as Clinical-Stage Biopharmaceutical Company Harnessing the Power of Soluble Guanylate Cyclase (sGC) Pharmacology for Treatment of Serious and Orphan Diseases Jun 17, 2019
News SIRION Biotech Licenses Technology to National Institute of Allergy and Infectious Diseases to Boost Clinical Efficacy of Lentivector Gene Therapy for X-linked SCID Jun 11, 2019
News PTC Therapeutics Receives FDA Approval for the Expansion of the EMFLAZA® (deflazacort) Labeling to Include Patients 2-5 Years Old Jun 10, 2019 Posted by PTC Therapeutics, Inc.
News REGENXBIO® Selects Skyland PIMS™ as their Process and Product Data Management System Jun 04, 2019
